Intravenous adenosine and lidocaine in patients with acute myocardial infarction

American Heart Journal

Volumn 136, Issue 2, 1998, Pages 196-204

  Garratt, Kirk N ^a   Holmes Jr , David R ^b   Molina Viamonte, Victor ^b   Reeder, Guy S ^b   Hodge, David O ^b   Bailey, Kent R ^b   Lobl, Joseph K ^b   Laudon, Dennis A ^b   Gibbons, Raymond J ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; LIDOCAINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION SIZE; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RESPIRATORY DISTRESS;

EID: 0031854292     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1053/hj.1998.v136.89910     Document Type: Article

References (49)

1. Jennings R, Yellon D. Reperfusion injury: definitions and historical background. In: Yellon DM, Jennings RB, editors. Myocardial protection: The pathophysiology of reperfusion and reperfusion injury. New York: Raven Press; 1992. p. 1-11.
2. Boiling SF, Bies LE, Gallagher KP, Bove EL. Enhanced myocardial protection with adenosine. Ann Thorac Surg 1989;47:809-15.
3. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation 1992;85:893-904.
4. Forman M, Velasco C, Jackson E. Adenosine attenuates reperfusion injury following regional myocardial ischemia. Cardiovasc Res 1993;27:9-17.
5. Pelleg A. Mechanisms of action and therapeutic potential of adenosine and its analogues in the treatment of cardiac arrhythmias. Coron Artery Dis 1993;4:109-15.
6. Pitarys C, Virmani R, Vildibill H, Jackson E, Forman M. Reduction of myocardial reperfusion injury by intravenous adenosine administration during the early reperfusion period. Circulation 1991;83:237-47.
7. Olafsson B, Forman MB, Puett DW, et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 1987;76:1135-45.
8. Lesnefsky E, VanBenthuysen K, McMurtry I, Shikes R, Johnston RJ, Horwitz L. Lidocaine reduces canine infarct size and decreases release of a lipid peroxidation product. J Cardiovasc Pharmacol 1989;13:895-901.
9. Flameng W. New strategies for intraoperative myocardial protection. Curr Opin Cardiol 1995;10:577-83.
10. Lasley RD, Mentzer R Jr. Preconditioning and its potential role in myocardial protection during cardiac surgery. J Cardiac Surg 1995;10:349-53.
11. Vinten-Johansen J, Zhao ZQ, Sato H. Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy. Ann Thorac Surg 1995;60:852-7.
12. Mentzer RM Jr, Rahko PS, Molina-Viamonte V, et al. Safety, tolerance, efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery. Am J Cardiol 1997;79:38-43.
13. Hudspeth DA, Nakanishi K, Vinten-Johansen J, et al. Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts. Ann Thorac Surg 1994;58:1637-44.
14. Topol EJ, Califf RM, George BS, et al. Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction. Circulation 1988;77:1100-7.
15. Zhou Z, Bunger R, Lasley R, Hegge J, Mentzer RJ. Adenosine pretreatment increases cytosolic phosphorylation potential and attenuates postischemic cardiac dysfunction in swine. Surg Forum 1993;44:249-52.
16. Verani MS, Mahmarian JJ. Myocardial perfusion scintigraphy during maximal coronary artery vasodilation with adenosine. Am J Cardiol 1991;67:12D-17D.
17. Okada R, Glover D, Gaffney T. Myocardial kinetics of technetium 99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1987;77:491-8.
18. Christian T, Gibbons R, Gersh B. The effect of infarct location on myocardial salvage assessed by Tc-99m-isonitrile. J Am Coll Cardiol 1991;17:1303-8.
19. Gibbons R, Verani M, Behrenbeck T, et al. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989;80:1277-86.
20. O'Connor M, Hammell T, Gibbons R. In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi). Eur J Nucl Med 1990;17:69-76.
21. Verani M, Jeroudi M, Mahmarian J, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion therapy using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988;12:1573-81.
22. Sinusas A, Trautman K, Bergin J, et al. Quantification of "area at risk" during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m-methoxyisobutyl-isonitrile. Circulation 1990;82:1424-37.
23. Christian T, Behrenbeck T, Pellika P, Huber K, Chesebro J, Gibbons R. Mismatches of left ventricular function and perfusion with Tc-99m-isonitrile following reperfusion therapy for acute myocardial infarctions: identification of myocardial stunning and hyperkinesia. J Am Coll Cardiol 1990;16:1632-8.
24. Christian T, Behrenbeck T, Gersh B, Gibbons R. Relation of left ventricular volume and function over one year following acute myocardial infarction to infarct size determined by Tc-99m-sestamibi. Am J Cardiol 1991;68:21-6.
25. Behrenbeck T, Pellika P, Huber K, Bresnahan J, Gersh B, Gibbons R. Primary PICA in myocardial infarction: assessment of myocardial salvage with Tc-99m-sestamibi. J Am Coll Cardiol 1991;17:365-73.
26. Wackers F, Gibbons R, Kayden D, et al. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy. J Am Coll Cardiol 1989;14:861-73.
27. Christian T, O'Connor M, Hopfenspirger M, Gibbons R. Comparison of reinjection thallium-201 and resting technetium-99m-sestamibi tomographic images for the quantification of infarct size following acute myocardial infarction. J Nucl Cardiol 1994;1:17-28.
28. Chareonthaitawee P, Christian T, Hirose K, Gibbons R, Rumberger J. Relation of initial infarct size to extent of ventricular remodelling in the year after acute myocardial infarction. J Am Coll Cardiol 1995;25:567-73.
29. Miller T, Christian T, Hopfenspirger M, Hodge D, Gersh B, Gibbons R. Infarct size after acute myocardial infarction measured by quantitative tomographic technetium-99m sestamibi imaging predicts subsequent mortality. Circulation 1995;92:334-41.
30. Medrano R, Weilbacher D, Young J, et al. Assessment of myocardial viability with technetium-99m sestamibi in patients undergoing cardiac transplantation: a scintigraphic-pathologic study. Circulation 1996;94:1010-7.
31. Christian T, Schwartz R, Gibbons RX, et al. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992;86:81-90.
32. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension 1991;18:565-74.
33. Chi L, Friedrichs GS, Oh JY, Green AL, Lucchesi BR. Effect of Ado A1- and A2-receptor activation on ventricular fibrillation during hypoxia-reoxygenation. Am J Physiol 1994;267:H1447-54.
34. Cerbai E, Klockner V, Isenberg G. Calcium-antagonistic effects of adenosine in guinea pig atrial cells. Am J Physiol 1988;255:H872-8.
35. Bertolet BD, McMurtrie EB, Hill JA, Belardinelli L. Theophylline for the treatment of atrioventricular block after myocardial infarction. Ann Intern Med 1995;123:509-11.
36. Gibbons R, Holmes D, Reeder G, Bailey K, Hopfenspirger M, Gersh B. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction: the Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med 1993;328:685-91.
37. Gersh B, Chesebro J, Clements I, Berger P. Acute myocardial infarction: management and complications. In: Giuliani E, Gersh B, McGoon M, Hayes D, Schaff H, editors. Mayo Clinic practice of cardiology. St. Louis: Mosby; 1996. p. 1257-1352.
38. Gersh B. Acute myocardial infarction: Arrhythmias. In: Giuliani E, Gersh B, McGoon M, Hayes D, Schaff H, editors. Mayo Clinic practice of cardiology. St. Louis: Mosby; 1996. p. 1353-86.
39. Behar S, Zissman E, Zion M, et al. Complete atrioventricular block complicating inferior acute wall myocardial infarction: short- and long-term prognosis. Am Heart J 1993;125:1622-7.
40. Berger PB, Ruocco N Jr, Ryan TJ, Frederick MM, Jacobs AK, Faxon DP. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II. J Am Coll Cardiol 1992;20:533-40.
41. Vaage-Nilsen M, Hansen JF, Mellemgaard K, Hagerup L, Sigurd B, Steinmetz E. Short- and long-term prognostic implications of in-hospital postinfarction arrhythmias: DAVIT II Study Group. Cardiology 1995;86:49-55.
42. Lee J, Heo J, Ogilby JD, Cave V, Iskandrian B, Iskandrian AS. Atrioventricular block during adenosine thallium imaging. Am Heart J 1992;123:1569-74.
43. Tebbenjohanns J, Pfeiffer D, Schumacher B, Jung W, Manz M, Luderitz B. Intravenous adenosine during atrioventricular reentrant tachycardia: induction of atrial fibrillation with rapid conduction over an accessory pathway. Pacing Clin Electrophysiol 1995;18:743-6.
44. Kabell G, Buchanan LV, Gibson JK, Belardinelli L. Effects of adenosine on atrial refractoriness and arrhythmias. Cardiovasc Res 1994;28:1385-9.
45. Garratt CJ, O'Nunain S, Griffith MJ, et al. Effects of intravenous adenosine in patients with preexcited junctional tachycardias: therapeutic efficacy and incidence of proarrhythmic events. Am J Cardiol 1994;74:401-4.
46. Chatterjee K. Complications of acute myocardial infarction: arrhythmias complicating myocardial infarction. Curr Probl Cardiol 1993;18:12-6.
47. Eldar M, Sievner Z, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S. Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality: the SPRINT Study Group. Ann Intern Med 1992;117:31-6.
48. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials. JAMA 1988;260:1910-6.
49. Pellika P, Behrenbeck T, Verani M, Mahmarian J, Wackers F, Gibbons R. Serial changes in myocardial perfusion using tomographic technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging following reperfusion therapy of myocardial infarction. J Nucl Med 1990;31:1269-75.